Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders.

ABSTRACT:

Introduction

Older adults with plasma cell disorders (PCDs) experience cognitive dysfunction that may be attributable to the disease and associated therapies. Yet, this has seldom been reported in the literature. Our objectives were to describe cognitive function (objective and patient-reported) in adults with PCDs and to explore clinical correlates of cognitive impairment.

Materials and methods

Participants completed a geriatric assessment between March 2018 and February 2020. Cognitive function was evaluated using two objective measures - Montreal Cognitive Assessment (MoCA, cutpoint <26) and Blessed Orientation Memory Concentration Test (BOMC, cutpoint >4) - and two patient-reported outcome (PRO) measures - Patient-Reported Outcomes Measurement Information System Cognitiv

SUBMITTER: Nakamura ZM 

PROVIDER: S-EPMC10024927 | biostudies-literature | 2022 Sep

REPOSITORIES: biostudies-literature